Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AMAG Pharmaceuticals Inc

+ Add to Watchlist

AMU:GR

49.200 EUR 1.389 2.75%

As of 02:08:21 ET on 05/06/2015.

Snapshot for AMAG Pharmaceuticals Inc (AMU)

Open: 49.110 Day's Range: 49.110 - 49.200 Volume: 0
Previous Close: 50.589 52wk Range: 12.340 - 56.370 1-Yr Rtn: +268.82%

Stock Chart for AMU

No chart data available.
  • AMU:GR 49.200
  • 1M
  • 1Y
50.589
Interactive AMU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AMU

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 11.3911
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) 4.8500
Est. PEG Ratio -
Market Cap (M EUR) 1,502.04
Shares Outstanding (M) 30.53
30 Day Average Volume 220
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AMU

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AMU

AMAG Pharmaceuticals, Inc., a biopharmaceutical company, utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease.

William K HeidenChief Executive OfficerFrank E ThomasPresident/COO
Kenneth A WilsonPres:Lumara Health/Senior VP:Sales & MktgScott A HolmesSenior VP:Finance/CAO
More Company Profile & Key Executives for AMU

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil